American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,302 | 29,629 | 19,601 | 7,155 | 47,087 |
| Depreciation Amortization | 13,367 | 10,110 | 6,990 | 3,572 | 10,345 |
| Income taxes - deferred | -978 | -1,001 | 125 | 14 | 1,206 |
| Accounts receivable | -20,112 | -680 | 5,934 | 4,933 | -14,542 |
| Accounts payable and accrued liabilities | -4,791 | -2,206 | 261 | -1,933 | 4,855 |
| Other Working Capital | -27,027 | -2,701 | -1,659 | -7,213 | 610 |
| Other Operating Activity | 25,806 | 5,409 | -4,801 | -3,000 | 25,249 |
| Operating Cash Flow | $27,568 | $38,560 | $26,452 | $3,529 | $74,810 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,886 | -1,446 | -685 | -394 | -73,127 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -53,056 |
| Purchase Of Investment | -239 | -239 | -173 | -105 | -22,380 |
| Purchase Sale Intangibles | -1,119 | -758 | -757 | N/A | -99,547 |
| Other Investing Activity | -2,631 | 5,278 | 5,278 | 0 | -108,812 |
| Investing Cash Flow | $-6,756 | $3,593 | $4,421 | $-500 | $-257,374 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,952 | 9,181 | 1,022 | 119,839 |
| Debt Repayment | N/A | -8,270 | -10,210 | N/A | -11,468 |
| Other Financing Activity | 1,807 | 0 | 0 | -1,004 | -29,999 |
| Financing Cash Flow | $1,807 | $1,682 | $-1,028 | $18 | $78,372 |
| Exchange Rate Effect | 447 | 125 | 206 | 216 | 5,843 |
| Beginning Cash Position | 68,061 | 68,061 | 68,061 | 70,637 | 166,410 |
| End Cash Position | 91,127 | 112,020 | 98,111 | 73,900 | 68,061 |
| Net Cash Flow | $23,066 | $43,959 | $30,050 | $3,263 | $-98,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,568 | 38,560 | 26,452 | 3,529 | 74,810 |
| Capital Expenditure | -3,980 | -1,499 | -685 | -395 | -73,136 |
| Free Cash Flow | 23,588 | 37,061 | 25,767 | 3,134 | 1,674 |